The opinions and assertions contained herein are private and are not to be construed as official or representing those of the Uniformed Services University of the Health Sciences or the Department of Defense, U.S.A.
MaherJ.F.Cardiac complications of uremia and dialysis. In: MaherJ.F., ed. Replacement of renal function by dialysis.Dordrecht: Kluwer Academic, 1989: 788–97.
2.
BryngerH., BrunnerF.P., ChantlerC.Combined report on regular dialysis and transplantation in Europe X, 1979.Proc Eur Dial Transplant Assoc1980; 17: 2–84.
3.
HeldP.J., PortF.K., WebbR.L.Excerptsfrom United States Renal Data System 1991 Annual Data Report.Am J Kidney Dis1991; 18(Suppl 2): 1–127.
4.
HiltonT.C., ChaitmanB.R.The prognosis in stable and unstable angina.Cardiol Clin1991; 9: 27–36.
5.
FirthB.G., YancyC.W.Survival in congestive heart failure: Have we made a difference?Am J Med1990; 88: 3N-7N.
6.
VlachojannisJ., KurzP., HoppeD.CAPD in elderly patients with cardiovascular risk factors.Clin Nephrol1988; 30(Suppl 1): S137.
7.
HutingJ., KramerW., ReitingerJ., KuhnK., WizemannV., SchutterleG.Cardiac structure and function in continuous ambulatory peritoneal dialysis: Influence of blood purification and hypercirculation.Am Heart J1990; 119: 344–52.
8.
AlpertM.A., Van StoneJ., TwardowskiZ.J.Comparative cardiac effects of hemodialysis and continuous ambulatory peritoneal dialysis.Clin Cardiol1986; 9: 52–60.
9.
GiangrandeA.Cardiovascular system in continuous ambulatory peritoneal dialysis.Contrib Nephrol1990; 84: 52–9.
MaK.W., GreeneE.L., RaijL.Cardiovascular risk factors in chronic renal failure and hemodialysis populations.Am J Kidney Dis1992; 19: 505–13.
12.
FuhM.M.T., LeeC.M., JengC.Y.Effect of chronic renal failure on high density lipoprotein kinetics.Kidney Int1990; 37: 1295–300.
13.
BonominiV., FelettiC., ScolariM.P., StefoniS., VangelistaA.Atherosclerosis in uremia: A longitudinal study.Am J Clin Nutr1980; 33: 1493–500.
14.
CattranD.C., FentonS.S.A., WilsonD.R., SteinerG.Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.Ann Intern Med1976; 85: 29–33.
15.
LameireN., MatthysD., MatthysE., BeheydtR.Effects of long-term CAPD on carbohydrate and lipid metabolism.Clin Nephrol1988; 30(Suppl 1): S53–8.
16.
BoeschotenE.W., ZuyderhoudtF.M.J., KredietR.T., AriszL.Changes in weight and lipid concentrations during CAPD treatment.Perit Dial Int1988; 8: 19–24.
17.
SakaiR., NishiokaM., KomabaK., OkudairaH., GotoT.Marked hyperlipidemia in two patients on long-term CAPD. In: OtaK., MaherJ., WinchesterJ., HirszelP., eds. Current concepts in peritoneal dialysis.Amsterdam: Elsevier Science, 1992: 549–54.
18.
AvramM.M., FeinP.A., AntignaniA.Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of he modialysis and continuous ambulatory peritoneal dialysis.Am J Med1989; 87(Suppl): 55N–60N.
19.
KaganA., Bar-KhayimY., SchaferZ., FainaruM.Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels.Kidney Int1990; 37: 980–90.
20.
GaultM.H., LongerichL., PrabhakaranV., PurchaseL.Ischemic heart disease, serum cholesterol and apolipoproteins in CAPD.ASAIO Trans1991; M513–4.
21.
ShojiT., NishizawaY., NishitaniH., YamakawaM., MoriiH.Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.Metabolism1991; 40: 1002–8.
22.
Di PaoloB., Del RossoG., CatucciG.Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.ASAIO Trans1990; 36: M578–80.
23.
ChanM.K.Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: The role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.Metabolism1989; 38: 939–45.
24.
JonesR.G., DibbleJ.B., GibsonJ.Effect of dietary fish oil on lipid abnormalities in patients on continuous ambulatory peritoneal dialysis.Perit Dial Int1988; 8: 203–6.
